CLINICAL RESPONSES TO GEFITINIB RETREATMENT IN NON-SMALL-CELL-LUNG-CANCER ADENOCARCINOMA PATIENTS WHO BENEFITED FROM PRIOR EFFECTIVE GEFITINIB THERAPY: A RETROSPECTIVE ANALYSIS

被引：0
作者：
Li, Junling [1 ]
Yan, Wang [1 ]
Yuankai, Shi [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
gefitinb; NSCLC; adenocarcinoma; readministration;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1291 / S1292
页数：2
相关论文
共 50 条
[31]   Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study [J].
Chang, Alex ;
Parikh, Purvish ;
Thongprasert, Sumitra ;
Tan, Eng Huat ;
Perng, Reury- Perng ;
Ganzon, Domingo ;
Yang, Chih-Hsin ;
Tsao, Chao-Jung ;
Watkins, Claire ;
Botwood, Nick ;
Thatcher, Nick .
JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) :847-855
[32]   Curative effect analysis of different treatments for gefitinib-resistance advanced non-small cell lung cancer patients [J].
Shi, Hong ;
Zhang, Xiaoyan ;
Wang, Fei ;
Liu, Daoming .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09) :16064-16070
[33]   A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) [J].
Kim, Se Hyun ;
Shim, Hyo Sup ;
Cho, Jaeho ;
Jeong, Jae Heon ;
Kim, Sun Mi ;
Hong, Yun Kyoung ;
Sung, Ji Hee ;
Ha, Sang-Jun ;
Kim, Hye Ryun ;
Chang, Hyun ;
Kim, Joo Hang ;
Tania, Crombet ;
Cho, Byoung Chul .
LUNG CANCER, 2013, 79 (03) :270-275
[34]   Maintenance therapy with gefitinib after first-line chemotherapy in patients affected by advanced non-small cell lung cancer [J].
Mencoboni, M. ;
Bergaglio, M. ;
Serra, M. ;
Ivaldi, G. P. ;
Tredici, S. ;
Racchi, O. ;
Rebella, L. ;
Galbusera, V. ;
Grosso, M. ;
Faravelli, B. .
ANTICANCER RESEARCH, 2007, 27 (6C) :4425-4429
[35]   Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study [J].
Abdullah, Matin Mellor ;
Bhat, Amit ;
Mohamed, Ahmad Kamal ;
Ching, Foo Yoke ;
Ahmed, Nida ;
Gantotti, Sandeep .
ONCOLOGY LETTERS, 2016, 11 (04) :2757-2762
[36]   Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR [J].
Miyauchi, Eisaku ;
Morita, Satoshi ;
Nakamura, Atsushi ;
Hosomi, Yukio ;
Watanabe, Kana ;
Ikeda, Satoshi ;
Seike, Masahiro ;
Fujita, Yuka ;
Minato, Koichi ;
Ko, Ryo ;
Harada, Toshiyuki ;
Hagiwara, Koichi ;
Kobayashi, Kunihiko ;
Nukiwa, Toshihiro ;
Inoue, Akira .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) :3587-+
[37]   Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China [J].
Shu, Yamin ;
Zhang, Qilin ;
He, Xucheng ;
Chen, Li .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :8297-8306
[38]   Comparison of Gefitinib Versus Chemotherapy in Patients with Non-small Cell Lung Cancer with Exon 19 Deletion [J].
Watanabe, Satoshi ;
Inoue, Akira ;
Nukiwa, Toshihiro ;
Kobayashi, Kunihiko .
ANTICANCER RESEARCH, 2015, 35 (12) :6957-6961
[39]   Gefitinib (ZD1839):: Therapy in selected patients with non-small cell tung cancer (NSCLC)? [J].
Dongiovanni, Diego ;
Daniele, Lorenzo ;
Barone, Carla ;
Dongiovanni, Vincenzo ;
Fissore, Camilla ;
Sapino, Anna ;
Macri, Luigia ;
Bussolati, Giovanni ;
Buffoni, Lucio ;
Gaspari, Fabio ;
Grillo, Raffaella ;
Birocco, Nadia ;
Addeo, Alfredo ;
Ciuffreda, Libero ;
Schena, Marina .
LUNG CANCER, 2008, 61 (01) :73-81
[40]   Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations [J].
Pham Van Luan ;
Nguyen Dinh Tien ;
Nguyen Minh Hai ;
Nguyen Dao Tien ;
Thi Thi Duyen .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
12345